MYOC基因p.Gln368Ter突变与正常眼压性青光眼的相关性
该病例对照研究评估了MYOC基因p.Gln368Ter突变在正常眼压性青光眼(NTG)患者中的角色。
要点
- p.Gln368Ter突变可在眼压≤21 mmHg的NTG患者中检出,频率低于高眼压患者。
核心结论
- p.Gln368Ter突变存在于眼压≤21 mmHg的NTG患者中,频率低于既往在高眼压患者中报道的水平。
- 该突变可能与正常眼压及眼压>21 mmHg患者的青光眼均相关。
研究设计与样本
- 病例对照研究,评估NTG患者中p.Gln368Ter突变的患病率。
- 队列1:美国(爱荷华、明尼苏达、纽约)和英格兰的772例NTG患者与2152例对照。
- 队列2:马萨诸塞眼耳医院和NEIGHBORHOOD联盟的561例NTG患者与2606例对照。
- 基因分型采用实时聚合酶链反应并经Sanger测序确认、全基因组关联研究数据插补或全外显子测序分析。
- 数据分析时间为2007年4月至2018年4月。
主要发现
- 总参与者6091例,其中女性3346例(54.9%),白人5799例(95.2%)。
关键数值与推荐
- NTG定义:眼压≤21 mmHg。
- 主要结局指标:采用Fisher精确检验比较NTG病例与对照之间p.Gln368Ter突变频率。
临床怎么用
- 对NTG患者可考虑MYOC基因p.Gln368Ter突变的检测,尤其在有家族史或遗传咨询需求时。
- 即使眼压正常,携带p.Gln368Ter突变者仍需警惕青光眼风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Mutations in the myocilin (MYOC) gene are the most common molecularly defined cause of primary open-angle glaucoma that typically occurs in patients with high intraocular pressures (IOP). One MYOC mutation, p.Gln368Ter, has been associated with as many as 1.6% of primary open-angle glaucoma cases that had a mean maximum recorded IOP of 30 mm Hg. However, to our knowledge, the role of the p.Gln368Ter mutation in patients with normal-tension glaucoma (NTG) with an IOP of 21 mm Hg or lower has not been investigated. OBJECTIVE: To evaluate the role of the p.Gln368Ter MYOC mutation in patients with NTG. DESIGN, SETTING, AND PARTICIPANTS: In this case-control study of the prevalence of the p.Gln368Ter mutation in patients with NTG, cohort 1 was composed of 772 patients with NTG and 2152 controls from the United States (Iowa, Minnesota, and New York) and England and cohort 2 was composed of 561 patients with NTG and 2606 controls from the Massachusetts Eye and Ear Infirmary and the NEIGHBORHOOD consortium. Genotyping was conducted using real-time polymerase chain reaction that was confirmed with Sanger sequencing, the imputation of genome-wide association study data, or an analysis of whole-exome sequence data. Data analysis occurred between April 2007 and April 2018. MAIN OUTCOMES AND MEASURES: Comparison of the frequency of the p.Gln368Ter MYOC mutation between NTG cases and controls with the Fisher exact test. RESULTS: Of 6091 total participants, 3346 (54.9%) were women and 5799 (95.2%) were white. We detected the p.Gln368Ter mutation in 7 of 772 patients with NTG (0.91%) and 7 of 2152 controls (0.33%) in cohort 1 (P = .03). In cohort 2, we detected the p.Gln368Ter mutation in 4 of 561 patients with NTG (0.71%) and 10 of 2606 controls (0.38%; P = .15). When the cohorts were analyzed as a group, the p.Gln368Ter mutation was associated with NTG (odds ratio, 2.3; 95% CI, 0.98-5.3; P = .04). CONCLUSIONS AND RELEVANCE: In cohorts 1 and 2, the p.Gln368Ter mutation in MYOC was found in patients with IOPs that were 21 mm Hg or lower (NTG), although at a frequency that is lower than previously detected in patients with higher IOP. These data suggest that the p.Gln368Ter mutation may be associated with glaucoma in patients with normal IOPs as well as in patients with IOPs that are greater than 21 mm Hg.
引用
- Alward WLM, van der Heide C, Khanna CL, et al. Myocilin Mutations in Patients With Normal-Tension Glaucoma. JAMA Ophthalmol. 2019. PMID: 30816940. doi:10.1001/jamaophthalmol.2019.0005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。